🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on October 14 at age 51 after a personal fight with pancreatic malignancy.

“The brilliant light of our household has faded away for us in this life,” his family stated. “After a prolonged and brave struggle with the disease, we are heartbroken to announce that Michael D’Angelo Archer, known to his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his innovative modern soul style and collaborations with renowned musicians.

He released his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The album reached the fourth spot on Billboard’s Top R&B Albums chart, earned platinum status soon after, and received multiple Grammy nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his music career into the limelight. The album premiered at No. 1 on both the R&B charts and the Billboard 200. He received two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a hesitant one, in the public consciousness. The personal depiction showed the singer, famously stripped down to his waist, singing straight into the camera.

D’Angelo retreated from the spotlight after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a severe car crash that put him in critical condition.

More than a decade later, his third and final album, “Black Messiah” (2014), confirmed his lasting popularity with another top chart entry on the soul music rankings and a award for Top R&B Record.

Once more, in his own mysterious way, D’Angelo made only a few public appearances in the following years.

The musician was scheduled as a headliner for the 2025 Roots Picnic festival, but his appearance was canceled, due to an “unexpected health issue.”

Although information is limited about D’Angelo’s health in the weeks before his death, he had apparently been hospitalized for an extended period and in palliative care for two weeks.

D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic malignancy, one of the most deadly and hardest to prevent types of the disease, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only provide dear memories with his loved ones, but we are eternally grateful for the legacy of deeply emotional music he leaves behind,” his family said.

Pancreatic Malignancy: Lethal and Difficult to Avoid

Pancreatic malignancy impacts the pancreas, a small organ that produces insulin and plays an essential role in digestion, among additional roles. The size and location of the organ in the human system make it more difficult to identify malignancy.

Although pancreatic cancer accounts for only about 3% of malignancy cases annually in the U.S., it is causes seven percent of cancer deaths.

Almost 70,000 people will be diagnosed with this condition and roughly 52,000 will succumb to the disease in the year 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have limited and poor treatment options, and a narrow opportunity to make a meaningful impact on the well-being of patients,” said a cancer specialist.

Since this disease seldom produces early symptoms, it’s often diagnosed only after the disease is late-stage. Although a individual has symptoms they are usually vague and may be confused with a several common illnesses.

“As of yet, there is no effective method to identify this malignancy in the initial phases, apart from listening to your body and consulting your doctor if there are new or unusual symptoms,” said a medical director.

Common symptoms of this disease encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s demise is an exception, as pancreatic cancer is most common in individuals in the sixty-five to seventy-five range. However, numerous malignancies, including pancreatic cancer, have become increasingly prevalent in younger adults.

“Pancreatic cancer diagnosed prior to fifty is deemed uncommon, yet alarmingly, doctors are noticing a rising count of younger patients affected by this condition,” said a expert.

Family History Impacts Disease Probability

Without effective screening tools for this malignancy, professionals emphasized the significance of understanding your relatives’ cancer history. Certain risk factors, such as smoking and excess weight also have an influence in the onset of pancreatic cancer.

Black individuals have the highest incidence of pancreatic cancer in the U.S. and are most likely to be diagnosed with untreatable disease.

“The first step toward reducing one’s risk of pancreatic cancer is understanding individual susceptibility. Individuals should examine their genetic background, hereditary factors, and medical conditions, such as diabetes, chronic pancreatitis, or obesity that may raise their susceptibility,” advised a medical professional.

Inherited genetic elements are associated with as much as 10% of all this malignancy instances. If someone in your family has had this disease, you may want to think about genetic testing.

“For people with a relative’s background of this condition or those having high risk genetic mutations, screening may involve advanced imaging such as MRI scans or endoscopic ultrasound (EUS) to find early changes in the organ,” he clarified.

For those looking to lower their chance, habit adjustments may make a difference. The best action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you are a non-smoker, stay away altogether.

Heavy drinking is linked to pancreatitis, a risk factor for pancreatic cancer, so limiting or abstaining from drinks may assist reduce your risk.

Managing your body mass or losing weight may also aid reduce your risk. Individuals with excess weight are twenty percent more prone to get this disease. This malignancy also is more frequent in those with diabetes, and reducing weight can also reduce the risk of type 2 diabetes.

Despite pancreatic cancer’s grim outlook, there is still hope.

“We are doing better with treatments and newer mixed drug treatments. There are emerging targeted therapies that already are showing results,” remarked a expert.

For numerous individuals, however, education about this uncommon but {dev